Research

Understanding the Stages of Mesothelioma at M. D. Anderson Cancer Center
At the M. D. Anderson Cancer Center, a team of multidisciplinary scientists and physicians have made significant strides in developing more accurate methods of surgical staging for malignant pleural mesothelioma...more

Role of Asbestos in the Development of Mesothelioma Studied by IMP Research Team
IMP researcher's in Boston continue to investigate the role of asbestos in the development of mesothelioma. They hope these studies will improve mesothelioma patient treatment and recovery...more

Recent Survey Leads to Greater Focus on Pain Management for Cancer Victims
the American Pain Foundation has turned its attention to raising awareness and research to “breakthrough cancer pain,”… This research is an important step toward helping patients better tolerate medical treatments and improving their quality of life...more

Oxaliplatin (Eloxatin) – Mesothelioma Treatment When Pemetrexed (Alimta) and Cisplatin Stop Working
Columbia University opened a new clinical trial that began recruiting patients with mesothelioma that will use Bortezomib (Velcade) and Oxaliplatin (Eloxatin) for treatment...more

New Detection Test For Lung Cancer In Development
Through clinical trials and research, clinicians and researchers will continue to gain a better understanding of how cancer develops, and new procedures will continue to be developed to help provide better care for those who suffer mesothelioma...more

Mesothelioma Tumor Bank and Patient Registry at IMP Advance Research
the ability for researcher's to rapidly gather data about diseases is limited by the number of patients seen by the researcher’s… IMP in Boston has helped solve this problem and advance research because of its extensive tumor bank and patient registry...more

Genomics – International Mesothelioma Program (IMP) and Genentech Search for a Cure for Mesothelioma
Researchers at the IMP feel that the disease malignant mesothelioma, which is resistant to treatment, can be cured if the genetic mutations of the malignant cells can be understood...more

Genome Mapping of Mesothelioma Cells
If scientists can identify the specific mutations that have occurred within the DNA, then they can target their treatment therapies more directly. This approach offers hope for all patients with cancer, including those with mesothelioma...more

Forty Percent Of Cancers May Be Preventable
experts now claim that as many as 40 percent of cancers could be prevented by protecting against infections and by making lifestyle changes...more

Extreme Drug Resistance (EDR) – International Mesothelioma Program Develops Mesothelioma Treatment Aid
The EDR assay test could be an invaluable tool in the treatment of malignant pleural mesothelioma and peritoneal mesothelioma, diseases that have shown a wide variability in response to different chemotherapy agents...more

Enhanced Quality of Life for Mesothelioma Patients a Priority at the IMP
The International Mesothelioma Program has made significant progress in developing new treatments to extend the lives of mesothelioma patients...more

Emerging Approach In Cancer Research May Eventually Help Victims of Mesothelioma
Researchers are always looking for new ways to battle cancer. We know that new approaches, research, and discoveries related to all types of cancer can play an important role in finding better treatments, and eventually a cure for mesothelioma...more

Cutting Edge Mesothelioma Clinical Trials at Memorial Sloan-Kettering
Memorial Sloan-Kettering Cancer Center is at the forefront cutting-edge medical research and care for mesothelioma patients...more

Clinical Trials Advance Mesothelioma Treatment at International Mesothelioma Program (IMP)
the clinical trials being conducted at the IMP are at the forefront of state-of-the-art mesothelioma treatment...more